APOE and Alzheimer disease: Previous studies have reported AD pathology and ApoE ε4 associations in terms of odds ratios [5,19]; however reporting this association in terms of CERAD score frequency may provide a more detailed picture of the differences in AD pathology severity between ApoE ε4 carriers and non-carriers.